Humana Inc.
Humana Inc.
Your view on HUM
Overview
What the company does, where it operates, and who runs it.
About Humana Inc.
- Industry
- Medical - Healthcare Plans
- Sector
- Healthcare
- CEO
- James A. Rechtin
- Headquarters
- Humana Building, Louisville, KY, US
- Industry
- Medical - Healthcare Plans
- Sector
- Healthcare
- CEO
- James A. Rechtin
- Headquarters
- Humana Building, Louisville, KY, US
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals.
It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract.
Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties.
As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Stock Data
Price chart, volume, and trading data.
What moved it
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Humana Inc. from FRC's valuation model, read against the market price. HUM last traded at $461.12, 44.4× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Humana Inc.. Starting points for Humana Inc.: P/E 44.4, EPS $10.37, beta 0.74 — an Medical - Healthcare Plans name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Humana Inc.. Humana Inc. paid $3.54 per share over the last year — a 0.8% yield at the current $461.12 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Humana Inc.. Trailing twelve-month EPS for Humana Inc. stands at $10.37. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Current price
—
live quote
Analysts' target
$483.74
average of 19 firms, last 12 months
Analyst Ratings
- Strong Buy0
- Buy12
- Hold7
- Sell1
- Strong Sell0
Earnings Estimate
| EPS | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | -$7.59 | $13.48 | $9.54 | $18.77 |
| Low estimate | -$7.83 | $10.09 | $9.10 | $12.25 |
| High estimate | -$6.66 | $17.23 | $10.49 | $24.75 |
| No. of analysts | 16 | 12 | 15 | 16 |
| Year-ago EPS | -$3.96 | $10.31 | $9.84 | — |
| Growth | -91.7% | +30.7% | -3.1% | — |
Revenue Estimate
| Revenue | Current QtrDec 2026 | Next QtrMar 2027 | Current YearFY Dec 2026 | Next YearFY Dec 2027 |
|---|---|---|---|---|
| Avg. estimate | $41.33B | $43.39B | $162.89B | $173.99B |
| Low estimate | $40.59B | $40.09B | $161.73B | $159.62B |
| High estimate | $42.50B | $45.59B | $164.15B | $184.64B |
| No. of analysts | 12 | 8 | 12 | 16 |
| Year-ago revenue | $32.52B | $39.65B | $129.66B | — |
| Growth | +27.1% | +9.4% | +25.6% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0, MarketWatch; as of Nov 18, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Humana Inc.. Humana Inc. has reported as a listed company since 1981. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Peer companies
Market cap
- ALHCAlignment Healthcare, Inc.Medical - Healthcare Plans$1.6B
- CIThe Cigna GroupMedical - Healthcare Plans$79.1B
- CNCCentene CorporationMedical - Healthcare Plans$37.0B
- CVSCVS Health CorporationMedical - Healthcare Plans$113.3B
- ELVElevance Health Inc.Medical - Healthcare Plans$96.4B
- MOHMolina Healthcare, Inc.Medical - Healthcare Plans$12.2B
- OSCROscar Health, Inc.Medical - Healthcare Plans$8.1B
More Medical - Healthcare Plans companies
- MRAIMarpai, Inc.OTC$9M
- PFHOPacific Health Care Organization, Inc.OTC$17M
- PGNYProgyny, Inc.NASDAQ$2.7B
- UNHUnitedHealth Group IncorporatedNYSE$369.2B
- UNH.NEUnitedHealth Group IncNEO
- CLOVClover Health Investments, Corp.NASDAQ$2.6B
ETFs holding Humana Inc.
% of the fund
- VOOVanguard S&P 500 ETF$1.0T in assets0.08%
- VTIVanguard Total Stock Market ETF$689.2B in assets0.07%
- VOVanguard Mid-Cap ETF$103.4B in assets0.48%
- IVViShares Core SP 500 ETF$852.9B in assets0.08%
- PINKSimplify Health Care ETF$352M in assets5.09%
- IHFiShares US Healthcare Providers ETF$1.5B in assets4.78%
- DXG.TODynamic Active Global Dividend ETF$825M in assets3.83%
- RPVInvesco S&P 500 Pure Value ETF$1.8B in assets2.65%
Largest holders first, then the funds most concentrated in HUM.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Humana Inc., and how their positions are changing. At a $55.38B market value, institutional positions materially move Humana Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Humana Inc. executives and directors. Shares of Humana Inc. have traded between $206.87 and $315.35 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
About this section
U.S. Senate disclosures naming Humana Inc.. Humana Inc. is a $55.38B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming Humana Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Humana Inc.. Coverage tracks Humana Inc. within Medical - Healthcare Plans (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Humana Inc.